Popular antidepressant recalled for high levels of a potentially cancer-causing chemical
Nearly 375,000 bottles of a popular antidepressant are being recalled due to high levels of a potentially cancer-causing chemical.
Evidence dossier
Intelligence passport
Measured timeline
📍 How it ended
The FDA announced a recall of a popular antidepressant due to high levels of a potentially cancer-causing chemical. Nearly 375,000 bottles were recalled over the presence of this carcinogen impurity.
Epilogue added 106d ago, after coverage quieted.
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
- Velocity & Diffusion: Coverage exploded across 10 distinct news outlets with 10 published articles, achieving a live velocity of 8.
- Primary Driver: Nearly 375,000 bottles of a popular antidepressant are being recalled due to high levels of a potentially cancer-causing chemical.
- Predictive Outlook: Archynetys algorithmic models forecast this story will remain a dominant headline through tomorrow.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
A popular antidepressant is under recall due to elevated levels of a chemical linked to cancer. The recall affects nearly 375,000 bottles. Coverage from Dallas News, WCAX, and other outlets emphasizes the potential health risks and the FDA's involvement.
The FDA has announced the recall, highlighting the presence of a carcinogen. The recall is being widely reported by both local and national news outlets, including ABC News, NBC New York, and the Houston Chronicle. Coverage does not yet specify the manufacturer or the specific antidepressant involved.
Watch for updates on the manufacturer's response and any additional information from the FDA. Coverage does not yet specify whether the chemical is present in other medications.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 122d ago.
Coverage (10)
-
Nearly 375,000 bottles of antidepressant recalled over cancer-linked impurityDallas News · 124d ago
-
-
FDA Announces Recall of Popular Antidepressant Over Possible Carcinogen RiskHealth: Trusted and Empathetic Health and Wellness Information · 124d ago
-
-
Popular antidepressant recalled for high levels of a potentially cancer-causing chemicalKOLN | Nebraska Local News, Weather, Sports | Lincoln, NE · 124d ago
-
Antidepressant recalled due to presence of potentially cancer-causing impurityABC News - Breaking News, Latest News and Videos · 124d ago
-
-
Nearly 375,000 bottles of antidepressant recalled over cancer-linked impurityHouston Chronicle · 124d ago
-
Popular antidepressant recalled over high levels of a cancer-causing compoundNBC New York · 124d ago
-
Popular antidepressant recalled for high levels of a potentially cancer-causing chemicalAction News 5 · 124d ago
Quick answers
What is the name of the antidepressant being recalled?
Coverage does not yet specify the name of the antidepressant.
Who announced the recall?
The FDA announced the recall.
How many bottles are affected by the recall?
Nearly 375,000 bottles are affected by the recall.
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
Topics
Related trends
Over 4 million tubes of toothpaste recalled. See affected products
Millions of tubes of toothpaste recalled due to risk of life-threatening infection.
Is my GLP-1 safe? What to know about FDA's crackdown on copycat drugs
6 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Colon cancer is now the second-leading cause of cancer death
Younger adults are facing rising colon cancer rates, despite often having more advanced disease.
GLP-1 injections recalled nationwide. See affected products
GLP-1 injections recalled nationwide due to sterility concerns.
Column | A blood test for 50-plus cancers? One survivor is glad he took it.
A blood test for 50-plus cancers sparks debate on efficacy and ethics.
New AI tool can predict cancer survival by a single patient selfie, study suggests
A single selfie could reveal a cancer patient’s survival odds, according to a new AI study.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.